Effect of plasmid-mediated stable interferon-γ expression on proliferation and cell death in the SKOV-3 human ovarian cancer cell line

References

• Marth, C., Windbichler, G.H., Hausmaninger, H., Petru, E., Estermann, K., Pelzer, A., Mueller-Holzner, E. Interferon-γ in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study. Int. J. Gynecol. Cancer 2006, 16, 1522–1528.
   PubMed Web of Science ®Google Scholar
• Lynch, H.T., Casey, M.J., Snyder, C.L., Bewtra, C., Lynch, J.F., Butts, M., Godwin, A.K. Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. Mol. Oncol. 2009, 3, 97–137.
   PubMed Web of Science ®Google Scholar
• Qian, H.N., Liu, G.Z., Cao, S.J., Feng, J., Ye, X. The experimental study of ovarian carcinoma vaccine modified by human B7-1 and IFN-γ genes. Int. J. Gynecol. Cancer 2002, 12, 80–85.
   PubMed Web of Science ®Google Scholar
• Seppänen, M., Lin, L., Saarinen, R., Punnonen, R., Vihko, K.K. Regulation of ovarian UT-OC-2 carcinoma cells by cytokines: effects on cell proliferation, activation of transcription factors and apoptosis. Acta Obstet. Gynecol. Scand. 2008, 87, 902–909.
   PubMed Web of Science ®Google Scholar
• Yang, W., Li, X.Y. Anti-tumor effect of pEgr-interferon-γ-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism. Chin. Med. J. 2005, 118, 296–301.
   PubMed Web of Science ®Google Scholar
• Harvat, B.L., Seth, P., Jetten, A.M. The role of p27Kip1 in γ interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells. Oncogene 1997, 14, 2111–2122.
   PubMed Web of Science ®Google Scholar
• Maher, S.G., Romero-Weaver, A.L., Scarzello, A.J., Gamero, A.M. Interferon: cellular executioner or white knight? Curr. Med. Chem. 2007, 14, 1279–1289.
   PubMed Web of Science ®Google Scholar
• Windbichler, G.H., Hausmaninger, H., Stummvoll, W., Graf, A.H., Kainz, C., Lahodny, J., Denison, U., Müller-Holzner, E., Marth, C. Interferon-γ in the first-line therapy of ovarian cancer: a randomized phase III trial. Br. J. Cancer 2000, 82, 1138–1144.
   PubMed Web of Science ®Google Scholar
• Marth, C., Fiegl, H., Zeimet, A.G., Müller-Holzner, E., Deibl, M., Doppler, W., Daxenbichler, G. Interferon-γ expression is an independent prognostic factor in ovarian cancer. Am. J. Obstet. Gynecol. 2004, 191, 1598–1605.
   PubMed Web of Science ®Google Scholar
• Alberts, D.S., Marth, C., Alvarez, R.D., Johnson, G., Bidzinski, M., Kardatzke, D.R., Bradford, W.Z., Loutit, J., Kirn, D.H., Clouser, M.C., Markman, M. Randomized phase 3 trial of interferon γ-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survival. Gynecol. Oncol. 2008, 109, 174–181.
   PubMed Web of Science ®Google Scholar
• Zhang, L., Mi, J., Yu, Y., Yao, H., Chen, H., Li, M., Cao, X. IFN-γ gene therapy by intrasplenic hepatocyte transplantation: a novel strategy for reversing hepatic fibrosis in Schistosoma japonicum-infected mice. Parasite Immunol. 2001, 23, 11–17.
   PubMed Web of Science ®Google Scholar
• Fathallah-Shaykh, H.M., Zhao, L.J., Kafrouni, A.I., Smith, G.M., Forman, J. Gene transfer of IFN-γ into established brain tumors represses growth by antiangiogenesis. J. Immunol. 2000, 164, 217–222.
   PubMed Web of Science ®Google Scholar
• Indraccolo, S., Tisato, V., Tosello, V., Habeler, W., Esposito, G., Moserle, L., Stievano, L., Persano, L., Chieco-Bianchi, L., Amadori, A. Interferon-α gene therapy by lentiviral vectors contrasts ovarian cancer growth through angiogenesis inhibition. Hum. Gene Ther. 2005, 16, 957–970.
   PubMed Web of Science ®Google Scholar
• Wall, L., Burke, F., Smyth, J.F., Balkwill, F. The anti-proliferative activity of interferon-γ on ovarian cancer: in vitro and in vivo. Gynecol. Oncol. 2003, 88, S149–S151.
   PubMed Web of Science ®Google Scholar
• Recillas-Targa, F. Multiple strategies for gene transfer, expression, knockdown, and chromatin influence in mammalian cell lines and transgenic animals. Mol. Biotechnol. 2006, 34, 337–354.
   PubMed Web of Science ®Google Scholar
• Ikeda, H., Old, L.J., Schreiber, R.D. The roles of IFN γ in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 2002, 13, 95–109.
   PubMed Web of Science ®Google Scholar
• Park, M.Y., Kim, D.R., Jung, H.W., Yoon, H.I., Lee, J.H., Lee, C.T. Genetic immunotherapy of lung cancer using conditionally replicating adenovirus and adenovirus-interferon-β. Cancer Gene Ther. 2010, 17, 356–364.
   PubMed Web of Science ®Google Scholar
• Freedman, R.S., Kudelka, A.P., Kavanagh, J.J., Verschraegen, C., Edwards, C.L., Nash, M., Levy, L., Atkinson, E.N., Zhang, H.Z., Melichar, B., Patenia, R., Templin, S., Scott, W., Platsoucas, C.D. Clinical and biological effects of intraperitoneal injections of recombinant interferon-γ and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Clin. Cancer Res. 2000, 6, 2268–2278.
   PubMed Web of Science ®Google Scholar
• Schmeler, K.M., Vadhan-Raj, S., Ramirez, P.T., Apte, S.M., Cohen, L., Bassett, R.L., Iyer, R.B., Wolf, J.K., Levenback, C.L., Gershenson, D.M., Freedman, R.S. A phase II study of GM-CSF and rIFN-γ1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer. Gynecol. Oncol. 2009, 113, 210–215.
   PubMed Web of Science ®Google Scholar
• Barton, C., Davies, D., Balkwill, F., Burke, F. Involvement of both intrinsic and extrinsic pathways in IFN-γ-induced apoptosis that are enhanced with cisplatin. Eur. J. Cancer 2005, 41, 1474–1486.
   PubMed Web of Science ®Google Scholar
• Wall, L., Burke, F., Barton, C., Smyth, J., Balkwill, F. IFN-γ induces apoptosis in ovarian cancer cells in vivo and in vitro. Clin. Cancer Res. 2003, 9, 2487–2496.
   PubMed Web of Science ®Google Scholar
• Melichar, B., Solichová, D., Freedman, R.S. Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies. Int. J. Gynecol. Cancer 2006, 16, 240–252.
   PubMed Web of Science ®Google Scholar
• Inaba, T., Ino, K., Kajiyama, H., Yamamoto, E., Shibata, K., Nawa, A., Nagasaka, T., Akimoto, H., Takikawa, O., Kikkawa, F. Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma. Gynecol. Oncol. 2009, 115, 185–192.
   PubMed Web of Science ®Google Scholar
• Kim, E.J., Lee, J.M., Namkoong, S.E., Um, S.J., Park, J.S. Interferon regulatory factor-1 mediates interferon-γ-induced apoptosis in ovarian carcinoma cells. J. Cell. Biochem. 2002, 85, 369–380.
   PubMed Web of Science ®Google Scholar
• Rieder, J., Jahnke, R., Schloesser, M., Seibel, M., Czechowski, M., Marth, C., Hoffmann, G. Nitric oxide-dependent apoptosis in ovarian carcinoma cell lines. Gynecol. Oncol. 2001, 82, 172–176.
   PubMed Web of Science ®Google Scholar